UPDATE! New Permanent J Code for SAPHNELO (anifrolumab-fnia) injection, for intravenous use, 300 mg/2mL
The Centers for Medicare and Medicaid Services (CMS) assigned SAPHNELO a permanent J code (J0491) effective for dates of service on or after April 1, 2022.
Posted by